AbbVie's Q2 2026 Revenue Beats Expectations, EPS Misses
UKPulse Money Desk
Pharmaceutical company AbbVie reported its second-quarter 2026 results, with revenue exceeding forecasts while earnings per share (EPS) fell short.
- AbbVie's Q2 2026 revenue surpassed expectations.
- The company's Q2 2026 earnings per share (EPS) missed forecasts.
- AbbVie's stock reportedly slipped following the earnings call.
Pharmaceutical firm AbbVie announced its financial results for the second quarter of 2026. The company's revenue for the quarter reportedly exceeded analysts' expectations. However, its earnings per share (EPS) for the same period did not meet forecasts.
Following the release of these figures, AbbVie's stock reportedly experienced a slip.